Non-Invasive Prenatal Testing (NIPT) is a blood screening test performed as early as 10 weeks of pregnancy. It analyzes fetal DNA (cfDNA) in the mother's blood to screen for common chromosomal disorders like trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), and trisomy 13 (Patau syndrome), and can also determine the fetus’s sex.